ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Lombardi Recruits Adams-Campbell.

October 3, 2008

Orlando Health President Mark Rohl We Opted For A Florida-Centric Strategy

January 10, 2014

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986

ACS names new officers.

December 5, 2003

Review Group Urges Increased Funding For NCI AIDS Drug Discovery Program

December 3, 1999

In Brief NCI-FDA Relations Tops, DeVita Says; Upon Talks to Candidates For Prospective Division

November 24, 1978